Drug-driven reclassification of multiple tumour subtypes reveals intrinsic molecular concordance of therapy across histologically disparate cancers
Yue Xu, Jie Zheng, Zhaoqing Cai, Wang Li, Jens Köhler, Yao Dai, Xiaojie Cheng, Tao Wu, Fan Zhang, Haiyun Wang
This study reclassifies tumors based on drug response and genomic alterations, revealing molecular concordance in therapy across histologically different cancers.
bioRxiv · Mar 2, 2021 · PreprintBioinformatics